(Q37283147)

English

Personalized dosing of cyclophosphamide in the total body irradiation-cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancy

scientific article published on 18 March 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Personalized dosing of cyclophosphamide in the total body irradiation-cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancy (English)

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

phase II clinical trial

0 references

0 references

Frederick R. Appelbaum

5

object named as

F R Appelbaum

1 reference

Europe PubMed Central

19 August 2017

PMC publication ID

author name string

J S McCune

1

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

A Batchelder

2

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

K A Guthrie

3

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

R Witherspoon

4

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

B Phillips

6

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

P Vicini

7

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

D H Salinger

8

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

G B McDonald

9

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

language of work or name

0 references

publication date

18 March 2009

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

85

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

615-622

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

https://scigraph.springernature.com/pub.10.1038/clpt.2009.27

0 references

Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718578

6 September 2017

Review article: management of hepatic disease following haematopoietic cell transplant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718578

6 September 2017

High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718578

6 September 2017

Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718578

6 September 2017

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718578

28 September 2017

Real-time dose adjustment of cyclophosphamide in a preparative regimen for hematopoietic cell transplant: a Bayesian pharmacokinetic approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718578

26 June 2018

Cellular target of cyclophosphamide toxicity in the murine liver: role of glutathione and site of metabolic activation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718578

26 June 2018

Some suggestions for measuring predictive performance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718578

26 June 2018

Aplastic anaemia treated by marrow transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718578

26 June 2018

Radiation hepatology of the rat: microvascular fibrosis and enhancement of liver dysfunction by diet and drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718578

26 June 2018

Metabolism-based cyclophosphamide dosing for hematopoietic cell transplant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718578

3 September 2018

Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718578

3 September 2018

Diminishing the risk of nonrelapse mortality in hematopoietic stem cell transplantation: Prediction of exposure to the cyclophosphamide metabolite carboxyethylphosphoramide mustard

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718578

3 September 2018

Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718578

3 September 2018

Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718578

3 September 2018

Limits of HLA mismatching in unrelated hematopoietic cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19295506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Marrow transplanation in man following cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/19295506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19295506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Marked enzymuria after bone marrow transplantation: a correlate of veno-occlusive disease-induced "hepatorenal syndrome"

1 reference

https://pubmed.ncbi.nlm.nih.gov/19295506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19295506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/CLPT.2009.27

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37283147&oldid=2117470208"